Cargando…
Alberta Spinal Muscular Atrophy Newborn Screening—Results from Year 1 Pilot Project
Spinal muscular atrophy (SMA) is a progressive neuromuscular disease caused by biallelic pathogenic/likely pathogenic variants of the survival motor neuron 1 (SMN1) gene. Early diagnosis via newborn screening (NBS) and pre-symptomatic treatment are essential to optimize health outcomes for affected...
Autores principales: | Niri, Farshad, Nicholls, Jessie, Baptista Wyatt, Kelly, Walker, Christine, Price, Tiffany, Kelln, Rhonda, Hume, Stacey, Parboosingh, Jillian, Lilley, Margaret, Kolski, Hanna, Ridsdale, Ross, Muranyi, Andrew, Mah, Jean K., Bulman, Dennis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443376/ https://www.ncbi.nlm.nih.gov/pubmed/37606479 http://dx.doi.org/10.3390/ijns9030042 |
Ejemplares similares
-
Newborn Screening: Current Status in Alberta, Canada
por: De Souza, Andy, et al.
Publicado: (2019) -
The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing
por: Zhou, Janet R., et al.
Publicado: (2021) -
Evaluating the prevalence of lipid assessments in children in Alberta, Canada
por: Christian, Susan, et al.
Publicado: (2023) -
Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011) -
Progressive Muscular Atrophy
por: Omar, A.
Publicado: (1947)